Dendreon

Last updated: October 11, 2024

Founder Edgar G. Engleman
Founder Edgar G. Engleman
USA | Add Funding

Website: http://www.dendreon.com/

Dendreon was a biotechnology company produces immunotherapy for prostate cancer. Its cancer vaccine uses a patient’s own immune cells, which are collected, processed and infused back into the individual through an intravenous infusion that is completed in three cycles.